• July 13, 2024

The CDC Just Released A Study That Should Make The Vaxxed VERY Scared!

A new study shows that prolonging the interval between the first and second dose of COVID-19 vaccines for six to eight weeks has a chance of mitigating the risk of myocarditis/pericarditis and improving vaccine effectiveness. The CDC website published this new update according to the scientists on February 22nd.

The relative case of myocarditis caused by mRNA vaccine is higher in young males ages 12 to 39 years old and claimed this is rare, according to CDC.

The study recommended 3 or 4-week intervals for those who are moderate to severely immunocompromised, 65-year-old and above adults, and those who need rapid protection. This is due to the increased concern about community transmission.

The CDC had released a summary finding of the new study examining international data and policies about their preferential recommendations of an mRNA vaccine product.

Below are the summary findings of each country:

USA: Summary of Findings

Canada: Summary of findings

United Kingdom: Summary of findings

Nordic Countries: Nordic cohort, myocarditis results

Denmark: SARS-CoV-2 vaccination and myocarditis or myopericarditis: a population-based cohort study

France and Germany: Summary of findings

According to the summary of findings, the risk of myocarditis may be higher for Moderna than the Pfizer vaccine.

The study concluded that myocarditis and pericarditis may be associated with Moderna vs. Pfizer especially in males aged 18-29 years old and also with shorter primary series intervals.

Well, it’s too late for this study, billions of test vaccines were already given and now they are saying to extend the interval between shots or you could face myocarditis.

Sources: The Gateway Pundit, CDC


The Daily Allegiant